case_images: PMC7114806_01
case_images: Medications taken
case_images: 40780_2020_162_Fig1_HTML.jpg
case_images: PMC7114806_01_40780_2020_162_Fig1_HTML.jpg
case_images: Fig1
case_images: The main blood test results and dosing status are shown in Table 1 and Fig. 1.
case_images: Chest roentgenogram findings. Each image has ground-glass opacity in the lower lung fields on both sides. a Image taken on June 2, 20XX, in the standing position, tube voltage of 130 kV, and tube current of 250 mA. b Image taken on June 22, 20XX, in the standing position, tube voltage of 130 kV, and current of 250 mA
case_images: 40780_2020_162_Fig2_HTML.jpg
case_images: PMC7114806_01_40780_2020_162_Fig2_HTML.jpg
case_images: Fig2
case_images: C-reactive protein (CRP; 4.2 mg/dL) values, but sialylated carbohydrate antigen Krebs von den Lungen-6 (KL-6) value (303 U/mL) was within the normal value range. Chest roentgenogram demonstrated bilateral ground glass opacity (Fig. 2) in the lower lung fields, and chest computed tomography (CT) scans demonstrated significant ground-glass shadows in a mosaic pattern in the lower lobes of both lungs (Fig. 3). During outpatient care on day 36 (June 22, 20XX), the cough remained but the shadow had almost disappeared on the chest roentgenogram (Fig. 2).